Progesterone and the Estradiol Patch for Menopause

An estradiol patch releases estrogen steadily through the skin to relieve menopause symptoms such as hot flashes and night sweats, and oral micronized progesterone is added for women who still have a uterus to protect its lining. Both are generic versions of FDA-approved drugs. In November 2025 the FDA began removing boxed warning language about cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy labels, while keeping the endometrial cancer boxed warning for estrogen used alone.

Key takeaways

Hormone therapy is the most effective treatment for hot flashes and night sweats, according to the 2022 position statement of The North American Menopause Society.
For women under 60 or within 10 years of menopause onset without contraindications, the Society found the benefit-risk balance favorable for bothersome symptoms and bone protection.
Estrogen alone can thicken the uterus lining and raise endometrial cancer risk. A progestogen, such as progesterone, lowers that risk for women with a uterus.
In February 2026 the FDA approved the first updated labels for six hormone therapy products. Other products, including generics, are being updated over time.
Your provider sets the dose and reviews whether to continue at regular check-ins.

How the two medications work together

Estradiol is the main estrogen your ovaries make before menopause. As levels fall, many women notice hot flashes, night sweats, sleep disruption, vaginal dryness and bone loss. An estradiol patch replaces some of that estrogen through the skin. The Climara label lists these approved uses for estradiol patches:

Moderate to severe hot flashes and night sweats due to menopause.
Moderate to severe vaginal and vulvar symptoms due to menopause.
Low estrogen from certain ovarian or pituitary conditions.
Prevention of postmenopausal osteoporosis in women at significant risk.

Progesterone balances estrogen's effect on the uterus. Without it, estrogen can cause the lining to overgrow, which raises the risk of endometrial cancer. Oral micronized progesterone (brand Prometrium) is FDA-approved to prevent this overgrowth in postmenopausal women with a uterus who use estrogen. It is also approved for missed periods caused by low progesterone.

If you have had a hysterectomy, you generally do not need progesterone with estrogen. Your provider will confirm what fits your history.

What changed with the boxed warnings

Boxed warnings were added to hormone therapy labels in the early 2000s after the Women's Health Initiative (WHI) study. The FDA has since stated that the average WHI participant was 63, more than a decade past the typical age of menopause, and that the hormone formulation studied is no longer commonly used.

Date	FDA action
November 10, 2025	FDA announced it was starting to remove boxed warning statements on cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy labels, and asked manufacturers to submit updated labeling
November 2025	FDA said it would keep the boxed warning for endometrial cancer on systemic estrogen-alone products
February 2026	FDA approved the first updated labels for six products, covering estrogen plus progestogen, estrogen alone, progestogen alone and vaginal estrogen

What this means for you:

Labels are changing in stages. The leaflet in your box may still show older boxed warning language until that specific product's label is updated. The Prometrium label was revised in 2026 under this process.
The endometrial cancer warning stays for systemic estrogen used alone, which is why progesterone matters if you have a uterus.
Risks have not disappeared. Labels still describe risks such as blood clots, stroke, gallbladder disease and breast cancer in the warnings sections. The change is about how those risks are framed, especially for women who start therapy near menopause.
Timing matters. The HHS fact sheet repeats the labeled recommendation to start systemic hormone therapy within 10 years of menopause onset or before age 60, with timing and duration decided by you and your prescriber.

Who may be a good fit

Hormone therapy may suit you if you have bothersome hot flashes, night sweats or sleep disruption from menopause, you are under 60 or within about 10 years of your last period, and you have none of the conditions that rule it out.

The labels list these contraindications for estrogen, and your provider screens for each:

Unexplained vaginal bleeding.
Current or past breast cancer, or other estrogen-sensitive cancers.
Current or past blood clots in the legs or lungs.
Current or past stroke or heart attack.
Liver disease.
Known inherited clotting disorders.

Peanut allergy. Prometrium capsules contain peanut oil and should not be used by people allergic to peanuts. Tell your provider about any food allergies.

Drowsiness. Progesterone can cause drowsiness or dizziness, which is why it is commonly taken at bedtime. Use caution with driving until you know how it affects you.

Using the patch day to day

From the patch labels and MedlinePlus:

Apply to clean, dry skin on the lower abdomen below the waistline. Some brands also allow the upper buttock.
Never apply to the breasts.
Rotate sites and avoid using the same spot again within a week.
Avoid the waistband, where clothing can rub the patch loose.
If a patch falls off, follow your pharmacy instructions for reapplying or replacing it.
Fold used patches in half, sticky sides together, before throwing them away, since they still contain hormone.

Miami heat, pools and sweat can affect adhesion. Press the patch firmly for several seconds and check it after workouts.

Frequently asked questions

Did the FDA remove all warnings from hormone therapy?

No. The FDA removed boxed warning statements about cardiovascular disease, breast cancer and probable dementia, starting with six products approved in February 2026. The boxed warning for endometrial cancer with estrogen used alone remains, and other risks are still described in the labels.

Why do I need progesterone if I only want help with hot flashes?

If you have a uterus, estrogen alone can thicken its lining and increase the risk of endometrial cancer. Progesterone protects the lining. If you have had a hysterectomy, you usually do not need it.

Is the patch different from estrogen pills?

Both deliver estradiol, but the patch delivers it through the skin instead of through the digestive system and liver. The Menopause Society notes that risks differ by type, dose, route and timing, so your provider will choose the form that fits your history.

How long can I stay on hormone therapy?

There is no single cutoff. The Menopause Society recommends individualized decisions with periodic review of benefits and risks. Your provider will check in regularly to decide whether to continue, adjust or taper.

Talk to a licensed provider

If menopause symptoms are affecting your sleep, training or work, start a secure online visit. A licensed provider will review your health history, explain the benefits and risks for you, and decide whether a prescription for an estradiol patch, progesterone or both is appropriate.

Sources

Reviewed October 28, 2026.

This article is educational and is not medical advice. Rx programs require an online visit with a licensed provider. Results vary.